JUAN JOSÉ
LAHUERTA PALACIOS
Investigador ata 2020
![Foto de JUAN JOSÉ](/img/nophoto.png)
![Foto de Complejo Hospitalario Universitario Insular - Materno Infantil de Canarias](/img/noimage_org.png)
Complejo Hospitalario Universitario Insular - Materno Infantil de Canarias
Las Palmas de Gran Canaria, EspañaPublicacións en colaboración con investigadores/as de Complejo Hospitalario Universitario Insular - Materno Infantil de Canarias (6)
2015
-
Bortezomib-based induction therapy followed by intravenous busulfan-melphalan as conditioning regimen for patients with newly diagnosed multiple myeloma
Leukemia and Lymphoma, Vol. 56, Núm. 2, pp. 415-419
2013
-
Intravenous Busulfan and Melphalan as a Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Matched Comparison to a Melphalan-Only Approach
Biology of Blood and Marrow Transplantation, Vol. 19, Núm. 1, pp. 69-74
2011
-
Long-term prognostic significance of response in multiple myeloma after stem cell transplantation
Blood, Vol. 118, Núm. 3, pp. 529-534
2009
-
Single daily dose of intravenous busulfan and melphalan as a conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation: A phase II trial
Leukemia and Lymphoma, Vol. 50, Núm. 2, pp. 216-222
2008
2003
-
Tandem transplants with different high-dose regimens improve the complete remission rates in multiple myeloma. Results of a Grupo Español de Síndromes Linfoproliferativos/Trasplante Autólogo de Médula Ósea phase II trial
British Journal of Haematology, Vol. 120, Núm. 2, pp. 296-303